Multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in Chinese female patients with schizophrenia

被引：0
|
作者：
Zhi-ling Zhou
Xin Li
Huai-yan Peng
Xi-yong Yu
Ming Yang
Feng-li Su
Feng Wang
Rong-hua Zhu
Chun-yu Deng
Qiu-xiong Lin
Chuan-yue Wang
Wen-biao Li
Shu-guang Lin
Huan-de Li
机构：
[1] Clinical Pharmacy Research Institute,Vascular Surgery Department
[2] Xiangya Second Hospital,Department of Clinical Laboratory
[3] Central South University,undefined
[4] Research Center of Medical Science,undefined
[5] Guangdong Provincial People's Hospital,undefined
[6] Xiangya Second Hospital,undefined
[7] Central South University,undefined
[8] Third Xiangya Hospital,undefined
[9] Central South University,undefined
[10] Affiliated Beijing An Ding Hospital,undefined
[11] Capital University of Medical Science,undefined
来源：
Acta Pharmacologica Sinica | 2006年 / 27卷
关键词：
pharmacokinetics; risperidone; 9-hydroxyrisperidone; schizophrenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：381 / 386
页数：5
相关论文
共 50 条
  • [21] Plasma levels of risperidone and 9-hydroxyrisperidone are doubled in over sixty years olds
    Zernig, G
    Aichhorn, W
    Stuppäck, C
    Marksteiner, J
    Weiss, U
    Walch, T
    Kemmler, G
    Saria, A
    PHARMACOPSYCHIATRY, 2002, 35 (04) : VI - VII
  • [22] HPLC methods for the detection and quantification of risperidone and 9-hydroxyrisperidone from serum.
    English, SM
    Perel, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U454 - U454
  • [23] The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein
    Wang, JS
    Ruan, Y
    Taylor, RM
    Donovan, JL
    Markowitz, JS
    De Vane, CL
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (04): : 415 - 419
  • [24] Risperidone and 9-hydroxyrisperidone concentrations are not dependent on age or creatinine clearance among elderly subjects
    Maxwell, RA
    Sweet, RA
    Mulsant, BH
    Rosen, J
    Kirshner, MA
    Kastango, KB
    Pollock, BG
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2002, 15 (02) : 77 - 81
  • [25] Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia
    Nagasaki, T
    Ohkubo, T
    Sugawara, K
    Yasui, N
    Furukori, H
    Kaneko, S
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 19 (3-4) : 595 - 601
  • [26] IN-VIVO PHARMACOLOGICAL PROFILE OF 9-HYDROXYRISPERIDONE, THE MAJOR METABOLITE OF THE NOVEL ANTIPSYCHOTIC RISPERIDONE
    MEGENS, AAHP
    AWOUTERS, FHL
    DRUG DEVELOPMENT RESEARCH, 1994, 33 (04) : 399 - 412
  • [27] Factors influencing concentrations of risperidone and 9-hydroxyrisperidone in psychiatric outpatients taking immediate-release formulations of risperidone
    Guo, Zhihao
    Chen, Chunxiu
    Deng, Shuhua
    Lu, Haoyang
    Ni, Xiaojia
    Zhang, Ming
    Huang, Shanqing
    Wen, Yuguan
    Shang, Dewei
    Wang, Zhanzhang
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2024, 39 (01)
  • [28] LC with column-switching and spectrophotometric detection for determination of risperidone and 9-hydroxyrisperidone in human serum
    Kirschbaum, Katrin M.
    Finger, Susann
    Vogel, Friederike
    Burger, Rainer
    Gerlach, Manfred
    Riederer, Peter
    Hiemke, Christoph
    CHROMATOGRAPHIA, 2008, 67 (3-4) : 321 - 324
  • [29] Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry
    Flarakos, J
    Luo, W
    Aman, M
    Svinarov, D
    Gerber, N
    Vouros, P
    JOURNAL OF CHROMATOGRAPHY A, 2004, 1026 (1-2) : 175 - 183
  • [30] Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro
    Schmidt, A. J.
    Krieg, J. C.
    Clement, H. W.
    Hemmeter, U. M.
    Schulz, E.
    Vedder, H.
    Heiser, P.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (03) : 349 - 354
12345